| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/18/2009 | CA2401569C Low dose entecavir formulation and use |
| 08/18/2009 | CA2388731C Pharmaceutical products and methods of fabrication therefor |
| 08/18/2009 | CA2369444C Pharmaceutical compositions of erythropoietin |
| 08/18/2009 | CA2353835C Composition set and kit for use in intraocular surgery |
| 08/18/2009 | CA2335250C Temperature-sensitive liposomal formulation |
| 08/18/2009 | CA2315141C Pharmaceutical compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof |
| 08/18/2009 | CA2226425C Drug delivery compositions for improved stability of steroids |
| 08/18/2009 | CA2224150C Use of locally applied dna fragments |
| 08/18/2009 | CA2184841C Recombinant adenovirus coding for glial-derived neurotrophic factor (gdnf) |
| 08/17/2009 | CA2709732A1 Lower dosage strength imiquimod formulations and short dosing regimens for treating actinic keratosis |
| 08/13/2009 | WO2009100446A1 Compositions for delivery of cargo such as drugs proteins and/or genetic materials |
| 08/13/2009 | WO2009100275A2 Compositions and devices |
| 08/13/2009 | WO2009100271A1 Prevention of micronutrient deficiencies associated with common disabilities in the over 50 adult |
| 08/13/2009 | WO2009100216A1 Composition for sustained release delivery of proteins or peptides |
| 08/13/2009 | WO2009100181A2 Absorbent ingestible agents and associated methods of manufacture and use |
| 08/13/2009 | WO2009100176A2 Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
| 08/13/2009 | WO2009099831A2 Edible film-strips with modified release active ingredients |
| 08/13/2009 | WO2009099741A1 Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods |
| 08/13/2009 | WO2009099728A1 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 08/13/2009 | WO2009099719A2 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 08/13/2009 | WO2009099679A2 Treatment of disease conditions via administration of dna repair enzyme |
| 08/13/2009 | WO2009099670A2 Oligomer-cannabinoid conjugates |
| 08/13/2009 | WO2009099392A1 Compositions of phytosterols with enhanced bioavailability |
| 08/13/2009 | WO2009099132A1 Method for improving storage stability of glutathione |
| 08/13/2009 | WO2009099120A1 Aqueous dispersion containing polysaccharide particulate gel and method for producing the same |
| 08/13/2009 | WO2009098716A2 Stabilized aqueous formulation containing paracetamol |
| 08/13/2009 | WO2009098710A1 Formocresol gel |
| 08/13/2009 | WO2009098663A1 Pharmaceutical compositions of entacapone co-micronized with sugar alcohols |
| 08/13/2009 | WO2009098661A1 Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability |
| 08/13/2009 | WO2009098520A2 Composition and method for assisting swallowing |
| 08/13/2009 | WO2009098475A1 Structured surfactant systems and uses thereof |
| 08/13/2009 | WO2009098469A1 Novel compositions and uses thereof |
| 08/13/2009 | WO2009098318A1 Liquid formulation of fsh |
| 08/13/2009 | WO2009098169A1 Orally disintegrating tablets with speckled appearance |
| 08/13/2009 | WO2009098147A2 Conjugated molecules comprising a peptide derived from the cd4 receptor coupled to a polyanion for the treatment of aids |
| 08/13/2009 | WO2009074678A3 Anticancer conjugates of camptothecin to hyaluronic acid |
| 08/13/2009 | WO2009073517A3 Intravesical compositions with valrubicin for the treatment of bladder cancer |
| 08/13/2009 | WO2009073508A3 Polysaccharide gel compositions and methods for sustained delivery of drugs |
| 08/13/2009 | WO2009064457A3 Corticosteroid compositions |
| 08/13/2009 | WO2009058815A3 Lipoxin a4 protection for retinal cells |
| 08/13/2009 | WO2009047434A3 Use of carriers as preservatives and pharmaceutical composition containing same |
| 08/13/2009 | WO2009036933A3 Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles |
| 08/13/2009 | WO2009018175A3 Cyclic azapeptides as integrin markers |
| 08/13/2009 | WO2009017855A3 Aneurysm occlusion device containing bioactive and biocompatible copolymer shell and a liquid embolic agent and a biocompatible metallic frame member |
| 08/13/2009 | WO2009008727A3 Molecules for targeting compounds to various selected organs or tissues |
| 08/13/2009 | WO2009008725A3 Molecules for targeting compounds to various selected organs, tissues or tumor cells |
| 08/13/2009 | WO2008148839A3 Long-acting polymeric prodrugs of exendin |
| 08/13/2009 | WO2008140507A8 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof |
| 08/13/2009 | WO2008098364A8 Reducing post-operative adhesion formation with intraperitoneal glutamine |
| 08/13/2009 | WO2008083213A3 Stabilisation by preparing cyclodextrin inclusion complexes |
| 08/13/2009 | WO2008073448A3 Pharmaceutical formulations and methods for making the same |
| 08/13/2009 | WO2008031104A3 Antimicrobial compositions and related applications |
| 08/13/2009 | WO2007108749A8 Chimeric constructs between cancer-homing peptides and cell-penetrating peptides coupled to anticancer drugs and/or diagnostic agent/agents |
| 08/13/2009 | US20090204204 Drug/Drug Deliver Systems For The Prevention And Treatment Of Vascular Disease |
| 08/13/2009 | US20090203842 Macromolecular Conjugates And Processes For Preparing The Same |
| 08/13/2009 | US20090203803 N-acylated chitinous polymers and methods of use thereof |
| 08/13/2009 | US20090203802 Powder composition, a dispersion of powder in oil, and a cosmetic comprising the same |
| 08/13/2009 | US20090203799 Novel compositions comprising carotenoids |
| 08/13/2009 | US20090203798 Solid Pharmaceutical Compositions Comprising a SIP Receptor Agonist and a Sugar Alcohol |
| 08/13/2009 | US20090203768 Nucleic acid-containing complex |
| 08/13/2009 | US20090203709 Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor |
| 08/13/2009 | US20090203660 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
| 08/13/2009 | US20090203648 Modified phosphocalcic compound, injectable composition containing same |
| 08/13/2009 | US20090203619 Artificial platelets |
| 08/13/2009 | US20090203589 Chemically modified human growth hormone receptor antagonist conjugates |
| 08/13/2009 | US20090203584 Peptide-based Compounds |
| 08/13/2009 | US20090203576 Methods and compositons for pulmonary delivery of insulin |
| 08/13/2009 | US20090203575 metabolic diseases such as lysosomal storage diseases; therapeutic agent and a targeting moiety that binds a mannose-6-phosphate receptor |
| 08/13/2009 | US20090202639 Biomaterials Consisting of Sulphated Hyaluronic Acid and Gellan to be Used in the Prevention of Spinal Adhesions |
| 08/13/2009 | US20090202637 Oral pharmaceutical coated composition for pulsatile release |
| 08/13/2009 | US20090202619 Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative |
| 08/13/2009 | US20090202582 Water-Disposable or Water-Soluble Polymer Film as a Vehicle for Dermatologic and Cosmetic Active Agents |
| 08/13/2009 | US20090202575 Immunostimulatory nucleic acid molecules |
| 08/13/2009 | US20090202573 Polymeric conjugates containing positively-charged moieties |
| 08/13/2009 | US20090202572 Compositions and methods for modulating bone mass |
| 08/13/2009 | US20090202536 Antibody-drug conjugates and methods |
| 08/13/2009 | US20090202430 Composition for cytocompatible, injectable, self-gelling polysaccharide solutions for encapsulating and delivering live cells or biologically active factors |
| 08/13/2009 | CA2714547A1 Ruthenium compounds and compositions |
| 08/13/2009 | CA2714506A1 Composition for sustained release delivery of proteins or peptides |
| 08/13/2009 | CA2714505A1 Compositions for delivery of cargo such as drugs proteins and/or genetic materials |
| 08/13/2009 | CA2714477A1 Methods and compositions |
| 08/13/2009 | CA2714282A1 Conjugated molecules comprising a peptide derived from the cd4 receptor coupled to a polyanion for the treatment of aids |
| 08/13/2009 | CA2714200A1 Method for improving storage stability of glutathione |
| 08/13/2009 | CA2714113A1 Pharmaceutical compositions of entacapone co-micronized with sugar alcohols |
| 08/13/2009 | CA2714112A1 Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability |
| 08/13/2009 | CA2714015A1 Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| 08/13/2009 | CA2714007A1 Treatment of disease conditions via administration of dna repair enzyme |
| 08/13/2009 | CA2714002A1 Novel compositions and uses thereof |
| 08/13/2009 | CA2713504A1 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 08/13/2009 | CA2713386A1 Liquid formulation of fsh |
| 08/13/2009 | CA2713380A1 Compositions of phytosterols with enhanced bioavailability |
| 08/13/2009 | CA2713361A1 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor |
| 08/13/2009 | CA2712606A1 Modified leptin polypeptides and their uses |
| 08/13/2009 | CA2712518A1 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 08/13/2009 | CA2711974A1 Edible film-strips with modified release active ingredients |
| 08/13/2009 | CA2711407A1 Aqueous dispersion containing polysaccharide particulate gel and method for producing the same |
| 08/13/2009 | CA2706512A1 Compositions and devices |
| 08/12/2009 | EP2088140A1 Dihydrazide compounds, preparation and uses thereof |
| 08/12/2009 | EP2087912A1 ENVIRONMENT-RESPONDING siRNA CARRIER USING DISULFIDE-BRIDGED POLYMERIC MICELLE |
| 08/12/2009 | EP2087911A1 Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanion for the treatment of AIDS |